Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/08/2012US20120283267 Compositions and methods for the treatment of giardiasis
11/08/2012US20120283266 Lysine specific demethylase-1 inhibitors and their use
11/08/2012US20120283265 Compounds useful for treating aids
11/08/2012US20120283264 Oxazolidinones as Modulators of MGLUR5
11/08/2012US20120283263 Triazine-aryl-bis-indoles and process for preparation thereof
11/08/2012US20120283262 Pharmaceutical compositions comprising sigma receptor ligands
11/08/2012US20120283261 Substituted n-phenylpyrimidin-2-amine analogs as inhibitors of the axl kinase
11/08/2012US20120283260 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
11/08/2012US20120283259 Novel inhibitors
11/08/2012US20120283258 Mediators of hedgehog signaling pathways, compositions and uses related hereto
11/08/2012US20120283257 Pharmaceutical compounds
11/08/2012US20120283256 New heterocycle compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the app metabolism occurs
11/08/2012US20120283255 Urea derivatives, methods for their manufacture, and uses therefor
11/08/2012US20120283254 Novel benzofurane-piperidine compounds
11/08/2012US20120283253 Semi-Solid Delivery Vehicle and Pharmaceutical Compositions
11/08/2012US20120283252 Process for preparing pharmaceutical ophthalmic compositions
11/08/2012US20120283251 Deuterated 5,6-dihydro-1h-pyridin-2-one compounds
11/08/2012US20120283250 Methods and Compositions for Determining Hypersusceptibility of HIV-1 to Non-Nucleoside Reverse Transcriptase Inhibitors
11/08/2012US20120283249 Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
11/08/2012US20120283248 Composition and method for treating cognitive impairments in down syndrom subjects
11/08/2012US20120283247 Diazepane acetamide derivatives as selective 11b-hsd1 inhibitors
11/08/2012US20120283246 Novel parenteral carbamazepine formulation
11/08/2012US20120283245 Azabicyclo[3.1.0]hex-2-yl compounds, a process for their preparation and pharmaceutical compositions containing them
11/08/2012US20120283244 Association between 4-benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing it
11/08/2012US20120283243 Spiroindoline Modulators of Muscarinic Receptors
11/08/2012US20120283242 Di - substituted pyridine derivatives as anticancers
11/08/2012US20120283241 Imidazopyridazinecarbonitriles useful as kinase inhibitors
11/08/2012US20120283240 Analogs of Indole-3-Carbinol and Their Use as Agents Against Infection
11/08/2012US20120283239 1H-[1,2,3]TRIAZOLO[4,5-c]PYRIDINE-4-CARBONITRILE DERIVATIVES
11/08/2012US20120283238 Irak inhibitors and uses thereof
11/08/2012US20120283237 Novel cephalosporins useful as antibacterial agents
11/08/2012US20120283236 Porphyrin Catalysts and Methods of Use Thereof
11/08/2012US20120283234 Bile Acid Derivatives As FXR Ligands For The Prevention Or Treatment Of FXR-Mediated Diseases Or Conditions
11/08/2012US20120283233 Carrier composition
11/08/2012US20120283232 Process for making a pharmaceutical composition
11/08/2012US20120283231 Delivery Of Corticosteroids Through Iontophoresis
11/08/2012US20120283230 Pharmaceutical compositions
11/08/2012US20120283229 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
11/08/2012US20120283228 2alpha-Methyl and 2beta-Methyl Analogs of 19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 and Their Uses
11/08/2012US20120283227 (20S)-24-(p-Toluenesulfonyloxy)-25,26,27-Trinorvitamin D3 Analogs and Their Uses
11/08/2012US20120283226 Cosmetic Composition
11/08/2012US20120283225 Combination Therapy for Skin Disorders
11/08/2012US20120283224 Chemical structure comprising phosphates with polyol substructures for hair and skin cosmetics usage
11/08/2012US20120283223 Cerebral nerve cell neogenesis agent
11/08/2012US20120283222 Heteroarylcarboxylic acid ester derivative
11/08/2012US20120283221 Novel phosphonic acid compounds as inhibitors of serine proteases
11/08/2012US20120283220 Antofine and cryptopleurine derivatives as anticancer agents
11/08/2012US20120283219 Diaminopteridine derivatives
11/08/2012US20120283218 MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
11/08/2012US20120283217 Modulators of amyloid-beta production
11/08/2012US20120283215 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same
11/08/2012US20120283214 Cyclodextrin-based polymers for therapeutics delivery
11/08/2012US20120283213 Aryl/Alkyl Succinic Anhydride Hyaluronan Derivatives
11/08/2012US20120283212 Use of polysaccharides for treating stress and anxiety
11/08/2012US20120283211 Medical implants containing adenosine receptor agonists and methods for inhibitiing medical implant loosening
11/08/2012US20120283210 Maribavir isomers, compositions, methods of making and methods of using
11/08/2012US20120283209 Antibacterial aminoglycoside analogs
11/08/2012US20120283208 Antibacterial aminoglycoside analogs
11/08/2012US20120283207 Antibacterial aminoglycoside analogs
11/08/2012US20120283206 Combination comprising N--4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent.
11/08/2012US20120283205 Compositions and methods of delivery of pharmacological agents
11/08/2012US20120283204 Talarazole metabolites
11/08/2012US20120283203 Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia
11/08/2012US20120283202 Anti-wart pharmaceutical composition and method for treating wart
11/08/2012US20120283201 9-substituted minocycline compounds
11/08/2012US20120283200 Pharmaceutical composition and method for preventing or treating chronic heart disease
11/08/2012US20120283199 Neuroprotective ganglioside compositions for use in treating or diagnosing huntington's disease
11/08/2012US20120283198 Halogenated dideoxy sugar derivates, preparation method and application thereof
11/08/2012US20120283197 Compositions Comprising a Glucose Anti-Metabolite, BHA, and/or BHT
11/08/2012US20120283194 Inhibitors of Atypical Protein Kinase C and Their Use in Treating Hedgehog Pathway-Dependent Cancers
11/08/2012US20120283193 Manipulation of brain in a circuit-specific manner
11/08/2012US20120283190 Endothelin inhibitors for the treatment of rapidly progressive glomerulonephritis
11/08/2012US20120283188 Genes and proteins associated with angiogenesis and uses thereof
11/08/2012US20120283181 Crystal forms of saxagliptin and processes for preparing same
11/08/2012US20120283177 Novel schedules for administering combination therapies useful for treating persons afflicted with the human immunodeficiency virus (hiv)
11/08/2012US20120283175 Antibacterial compositions
11/08/2012US20120283094 Pesticidal bis-organosulfur compounds
11/08/2012US20120282622 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
11/08/2012US20120282359 Compositions, Kits, and Methods for the Treatment of Conditions Associated with Elevated Cholesterol Levels
11/08/2012US20120282358 Oral administration composition
11/08/2012US20120282353 Methods, compositions and articles of manufacture for hif modulating compounds
11/08/2012US20120282351 System and Method for The Prevention of Bacterial and Fungal Infections Including Urinary Tract Infections (UTI) Using N-Halogenated Amino Acids
11/08/2012US20120282350 Performance enhancing compositions and methods of use
11/08/2012US20120282346 Brimonidine compositions for treating erythema
11/08/2012US20120282343 Compositions for oral gene therapy and methods of using same
11/08/2012US20120282342 Method for preparing polysaccharide nanocomposite particles and uses of the same
11/08/2012US20120282341 Lipid Formulated Compositions And Methods For Inhibiting Expression Of Eg5 And VEGF Genes
11/08/2012US20120282340 Drug delivery system
11/08/2012US20120282339 Electrolyte purgative
11/08/2012US20120282338 Extended Release Formulation
11/08/2012US20120282337 Modified Release Formulation
11/08/2012US20120282336 Bilayer tablet formulations
11/08/2012US20120282335 Rapidly dispersing granules, orally disintegrating tablets and methods
11/08/2012US20120282334 Process for preparing ajoene from garlic
11/08/2012US20120282333 Delayed release pharmaceutical composition of mesalamine
11/08/2012US20120282332 Composition and method thereof
11/08/2012US20120282331 Mammalian metabolites of steroids
11/08/2012US20120282328 Dual action, inhaled formulations providing both an immediate and sustained release profile
11/08/2012US20120282327 Phosphate-containing nanoparticle delivery vehicle
11/08/2012US20120282326 Compositions and methods related to mirna in diabetic conditions
1 ... 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 ... 7860